Chemical Structure : PBT434 mesylate
CAS No.: 2387898-69-1
货号: PC-27216Not For Human Use, Lab Use Only.
PBT434 mesylate is a novel quinazolinone compound with effect of lowering cellular iron levels, prevents iron mediated neurodegeneration and α-synuclein toxicity in multiple models of Parkinson disease.
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 2 mg | ¥2180 | In stock | |
| 5 mg | ¥3580 | In stock | |
| 10 mg | ¥5580 | In stock | |
| 50 mg | Get quote | ||
| 100 mg | Get quote |
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
PBT434 mesylate is a novel quinazolinone compound with effect of lowering cellular iron levels, prevents iron mediated neurodegeneration and α-synuclein toxicity in multiple models of Parkinson disease.
PBT434 inhibits iron-mediated redox activity and iron-mediated aggregation of α-synuclein, a protein that aggregates in the neuropathology.
PBT434 prevents loss of substantia nigra pars compacta neurons (SNpc), lowers nigral α-synuclein accumulation, and rescues motor performance in mice model of PD.
| 分子量 | 398.26 | |
| 分子式 | C13H17Cl2N3O5S | |
| 外观性状 | Solid | |
| 储存条件 |
|
|
| Solubility |
10 mM in DMSO |
|
| Chemical Name/SMILES |
4(3H)-Quinazolinone, 5,7-dichloro-2-[(ethylamino)methyl]-8-hydroxy-3-methyl-, methanesulfonate (1:1) |
|
1. Finkelstein DI, et al. Acta Neuropathol Commun. 2017 Jun 28;5(1):53.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright